Sort
17,288 grants matching “multiple sclerosis”
Regulatory T cells in MBP-Specific Autoimmunity
$288,040University Of Washington · R01 · FY2004 · NS
Determinants of the Cannabinoid Receptor Life Cycle
$287,975Debra A Kendall · University Of Connecticut Storrs · R01 · FY2011 · DA
Project 5
$287,893Bibhuti Bhusan Mishra · University Of North Dakota · P20 · FY2020 · GM
Efficacy of flupirtine for treatment of neonatal hypoxic-ischemic encephalopathy
$287,882Yogendra H Raol · University Of Colorado Denver · R01 · FY2012 · HD
GSK3: immunoregulator in experimental autoimmune encephalomyelitis (EAE)
$287,847Patrizia De Sarno · University Of Alabama At Birmingham · R01 · FY2009 · NS
Brain Vascular Heterogeneity
$287,823Carlos A Pardo-Villamizar · Johns Hopkins University · R21 · FY2021 · NS
Multiple sclerosis as a cytodegenerative proteopathy
$287,793Peter K Stys · University Of Calgary · R01 · FY2023 · NS
Multiple sclerosis as a cytodegenerative proteopathy
$287,793Peter K Stys · University Of Calgary · R01 · FY2022 · NS
Multiple sclerosis as a cytodegenerative proteopathy
$287,793Peter K Stys · University Of Calgary · R01 · FY2025 · NS
Reactive astrogliosis regulates blood-brain barrier permeability.
$287,786Gareth R John · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · NS
Novel immunotherapy against MOG antibody disease
$287,733Greg Barrett · Evoq Therapeutics, Inc. · R43 · FY2022 · AI
PROBES OF CARBOHYDRATE FUNCTION
$287,670University Of Wisconsin Madison · R01 · FY2002 · GM
Immune Regulation of Neural Stem Cell Program In EAE
$287,616Samia J. Khoury · Brigham And Women'S Hospital · R01 · FY2006 · AI
MECHANISMS OF OLIGODENDROCYTE DIFFERENTIATION
$287,613New York University School Of Medicine · R01 · FY2003 · MH
In Vitro correlates of rapamycin therapy in MS patients
$287,613Brigham And Women'S Hospital · R01 · FY2004 · NS
In Vitro correlates of rapamycin therapy in MS patients
$287,613Brigham And Women'S Hospital · R01 · FY2003 · NS
The New Family of NEET Proteins: 2Fe-2S Protein Mediated Health and Disease
$287,606Patricia A Jennings · University Of California, San Diego · R01 · FY2012 · GM
Informed Consent in People with Multiple Sclerosis
$287,598Michael R Basso · University Of Tulsa · R01 · FY2007 · NS
Protection of Mice From Lethal Alphavirus Encephalitis
$287,594David N Irani · University Of Michigan At Ann Arbor · R01 · FY2008 · AI
Protection of Mice From Lethal Alphavirus Encephalitis
$287,594David N Irani · University Of Michigan At Ann Arbor · R01 · FY2009 · AI
IFNAR1 signaling through STAT3, PI-3 kinase and NFkB
$287,590Lawrence M Pfeffer · University Of Tennessee Health Sci Ctr · R01 · FY2007 · CA
Validation of Antibody Reagents for 15 High Priority AMP-AD Targets
$287,500Lara M Mangravite · Sage Bionetworks · RF1 · FY2019 · AG
Mechanisms of EAE Resistance and Development of Chronic Relapsing Disease
$287,467Harley Y. Tse · Wayne State University · R01 · FY2011 · NS
Lipid hydroxylation in glial cell signaling and myelination
$287,438Hiroko Hama · Medical University Of South Carolina · R01 · FY2009 · NS
Lipid hydroxylation in glial cell signaling and myelination
$287,438Hiroko Hama · Medical University Of South Carolina · R01 · FY2008 · NS